GLAXOSMITHKLINE CONSUMER HEALTHCARE INVESTMENTS (IRELAND) (NO.2) UNLIMITED COMPANY

Company number FC031629

Date	Type	Description	View / Download
05 Jul 2022	OSDS01	Closure of UK establishment(s) BR016698 and overseas company FC031629 on 23 May 2022	(2 pages)
01 Jul 2021	OSLQ01	Appointment of a liquidator of an overseas company	(3 pages)
01 Jul 2021	OSLQ03	Winding up of an overseas company	(3 pages)
11 May 2021	OSCH06	Secretary's details changed for Edinburgh Pharmaceutical Industries Limited on 1 January 2021	(4 pages)
10 Mar 2021	OSCH02	Details changed for an overseas company - Change in Accounts Details Ec	(4 pages)
10 Mar 2021	OSCH02	Details changed for an overseas company - Change in Objects 31/12/99 Null
23 Dec 2020	OSAP01	Appointment of Mr Hanief Ardiasyah Fadhol Arovah as a director on 31 July 2020	(3 pages)
17 Sep 2020	OSTM01	Termination of appointment of Antrinkos Andrew Aristidou as a director on 31 July 2020	(2 pages)
06 Apr 2020	OSTM01	Termination of appointment of Richard Philip Tattershall as a director on 10 March 2020	(2 pages)
06 Apr 2020	OSTM01	Termination of appointment of Richard Green as a director on 10 March 2020	(2 pages)
10 Nov 2019	OSAP01	Appointment of Mr Antrinkos Andrew Aristidou as a director on 19 August 2019	(3 pages)
28 May 2019	OSAP01	Appointment of Mr Aidan Lynch as a director on 10 April 2019	(3 pages)
24 May 2019	OSAP01	Appointment of Mr Eugene Prokopchuk as a director on 18 March 2019	(3 pages)
23 Feb 2019	OSAP01	Appointment of Mr Richard Green as a director on 15 January 2019	(3 pages)
07 Feb 2019	OSTM01	Termination of appointment of Melanie Foster-Hawes as a director on 15 January 2019	(2 pages)
01 Feb 2018	OSTM01	Termination of appointment of Jonathan Wilson Box as a director on 30 November 2017	(2 pages)
08 Dec 2017	OSAP01	Appointment of Richard Philip Tattershall as a director on 30 November 2017	(3 pages)
13 Jun 2017	OSCC01	Alteration of constitutional documents on 18 November 2016	(16 pages)
05 May 2017	OSNM01	Change of registered name of an overseas company on 27 April 2017 from Glaxosmithkline consumer healthcare investments (ireland) (no.2)	(4 pages)
19 Aug 2016	OSTM01	Termination of appointment of Adam Walker as a director on 1 August 2016	(2 pages)
19 Aug 2016	OSTM01	Termination of appointment of Alan George Burns as a director on 1 August 2016	(2 pages)
30 Jul 2016	OSAP01	Appointment of Jonathan Box as a director on 17 June 2016	(3 pages)
30 Jul 2016	OSAP01	Appointment of Melanie Foster-Hawes as a director on 17 June 2016	(3 pages)
08 Mar 2016	OSTM01	Termination of appointment of Paul Frederick Blackburn as a director on 1 March 2016	(2 pages)
14 Jul 2015	OSAP01	Appointment of Adam Walker as a director on 31 May 2015	(3 pages)